REQUEST A DEMO
Total
USD $0.00
Search more companies

Krka-Polska Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Krka-Polska Sp. z o.o. Profile Updated: February 02, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Krka was established in Poland in 1974. The company is manufacturing and distributing drugs: antibiotics, psychiatric and OTC drugs. The company also offers veterinary products. Krka Poland has production and distribution center in Warsaw.

Headquarters
Ul. Rownolegla 5
Warsaw; Mazowieckie; Postal Code: 02-235

Contact Details: Purchase the Krka-Polska Sp. z o.o. report to view the information.

Website: http://www.krkapolska.pl

Basic Information
Total Employees:
Purchase the Krka-Polska Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Krka-Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Krka-Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Krka-Polska Sp. z o.o. report to view the information.
Ratings:
Purchase the Krka-Polska Sp. z o.o. report to view the information.
Incorporation Date:
July 06, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Company Performance
Financial values in the chart are available after Krka-Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-9.98%
Total operating revenue
-9.63%
Operating profit (EBIT)
-0.13%
EBITDA
-0.28%
Net Profit (Loss) for the Period
-0.05%
Total assets
-5.04%
Total equity
-4.26%
Operating Profit Margin (ROS)
0.98%
Net Profit Margin
0.77%
Return on Equity (ROE)
0.73%
Quick Ratio
0.12%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?